GlassScriptPhysician profile
Carolyn Adele Hardin
NPI 1922422120
$1,747.73
in general payments reported to CMS, 2019-2025
17 companies · $487 in 2025
The $487 reported for 2025 was more than what a typical Mohs-Micrographic Surgery provider received nationally (typical 2025 total: $462).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $172 · 2023: $552 · 2024: $538 · 2025: $487.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,576.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,576.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $389.62 | 2024-2025 | Bimzelx |
| Lilly USA, LLC | $275.52 | 2022-2024 | Olumiant, Taltz, Ebglyss |
| Regeneron Healthcare Solutions, INC. | $167.38 | 2023-2024 | Dupixent, Libtayo |
| Incyte Corporation | $142.78 | 2023-2025 | Opzelura |
| Revance Therapeutics, INC. | $129.69 | 2024 | Daxi |
| Dermavant Sciences, INC. | $127.26 | 2023-2024 | Vtama |
| Janssen Biotech, INC. | $124.99 | 2023 | Tremfya |
| Genzyme Corporation | $121.82 | 2023 | |
| Galderma Laboratories, L.P. | $81.18 | 2022-2023 | Aklief |
| Sun Pharmaceutical Industries INC. | $28.27 | 2025 | |
| Amgen INC. | $26.55 | 2025 | Otezla |
| Organogenesis INC. | $26.14 | 2025 | Via Matrix |
| Next Science LLC | $25.67 | 2023 | Xperience, Surgx, Blastx |
| Biowound Solutions, INC. | $22.55 | 2025 | Bio-Connekt |
| Leo Pharma INC. | $22.22 | 2024 | Adbry |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $18.92 | 2025 | |
| Organon LLC | $17.17 | 2025 | Vtama |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carolyn Hardin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.